P. Bonetti

发表

Matthias Stuber, Juerg Schwitter, Thomas Schertler, 2006 .

Statin effects beyond lipid lowering--are they clinically relevant?

C. Napoli, L. Lerman, A. Lerman, 2003, European heart journal.

Studies on metabolically depleted erythrocytes.

P. Bonetti, W. Reinhart, T. Schulzki, 2014, Clinical hemorheology and microcirculation.

Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect.

R. Lavi, L. Lerman, A. Lerman, 2011, Atherosclerosis.

Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.

F. Eberli, M. Pfisterer, S. von Felten, 2014, American heart journal.

Endothelial function and cerebrovascular disease: Implications for diagnosis and treatment

A. Lerman, P. Bonetti, A. Elesber, 2006, Current treatment options in cardiovascular medicine.

Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering.

L. Lerman, D. Holmes, M. Rodriguez-Porcel, 2002, Journal of the American College of Cardiology.

Coronary stent infection: a rare but severe complication of percutaneous coronary intervention.

M. Pfisterer, P. Bonetti, B. Kaufmann, 2005, Swiss medical weekly.

Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions

M. Pfisterer, P. Buser, H. Brunner-La Rocca, 2008, Cardiology.

Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia.

L. Lerman, D. Holmes, M. Rodriguez-Porcel, 2003, Atherosclerosis.

Nonspecific Placebo Effects

P. Bonetti, 2012 .

Successful treatment of symptomatic coronary endothelial dysfunction with enhanced external counterpulsation.

A. Lerman, P. Bonetti, G. Barsness, 2004, Mayo Clinic proceedings.

Reduced incidence of acute myocardial infarction in the first year after implementation of a public smoking ban in Graubuenden, Switzerland.

P. Bonetti, W. Reinhart, T. Schulzki, 2010, Swiss medical weekly.

Complement inhibition to treat myocardial infarction?

P. Bonetti, G. Stussi, B. Gerber, 2011, BMJ Case Reports.

Effect of brief secondhand smoke exposure on endothelial function and circulating markers of inflammation.

P. Bonetti, W. Reinhart, M. Kuhn, 2011, Atherosclerosis.

Endothelial Dysfunction: A Marker of Atherosclerotic Risk

Amir Lerman, Lilach O Lerman, L. Lerman, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Quality of lipid management in patients with a history of myocardial infarction in general practice in Graubuenden, Switzerland

P. Bonetti, Oliver Sears, Walter H. Reinhart, 2011 .

A patient with pulmonary embolism and a mass in the left atrium

P. Bonetti, Reto Nägele, K. Mayer, 2012, Heart.

Abstract 3468: Clinical Safety and Long-Term Efficacy of Drug Eluting versus Bare Metal Stents in Acute ST-Elevation Myocardial Infarction

P. Hunziker, P. Buser, R. Jeger, 2006 .

Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease.

Amir Lerman, S. Higano, D. Holmes, 2003, Journal of the American College of Cardiology.

Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events

Amir Lerman, S. Higano, D. Holmes, 2003, Circulation.

ATVB in Focus Noninvasive Assessment of Atherosclerosis: from Structure to Function

L. Lerman, A. Lerman, P. Bonetti, 2003 .

Bosentan preserves endothelial function in mice overexpressing APP

Amir Lerman, Lilach O. Lerman, Xiang-Yang Zhu, 2006, Neurobiology of Aging.

Enhanced external counterpulsation for ischemic heart disease

D. Holmes, A. Lerman, P. Bonetti, 2010 .

Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain?

D. Holmes, A. Lerman, P. Bonetti, 2003, Journal of the American College of Cardiology.

Long-Term Benefits and Limitations of Combined Antianginal Drug Therapy in Elderly Patients with Symptomatic Chronic Coronary Artery Disease

M. Pfisterer, P. Erne, P. Bonetti, 2005, Journal of cardiovascular pharmacology and therapeutics.

Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectoris.

M. Pfisterer, P. Buser, R. Jeger, 2005, The American journal of cardiology.

Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia.

Amir Lerman, S. Higano, D. Holmes, 2004, Journal of the American College of Cardiology.

Noninvasive Assessment of Atherosclerosis : from Structure to Function Series

L. Lerman, A. Lerman, P. Bonetti, 2003 .

Drug-eluting versus bare-metal stents in large coronary arteries.

F. Eberli, M. Pfisterer, S. de Servi, 2010, The New England journal of medicine.

Incidence and time frame of life-threatening arrhythmias in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

P. Bonetti, W. Reinhart, P. Müller, 2012, Swiss medical weekly.

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.

F. Eberli, M. Pfisterer, S. de Servi, 2008, American heart journal.

Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.

F. Eberli, M. Pfisterer, S. de Servi, 2016, American heart journal.

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)

Christoph Kaiser, André Linka, M. Pfisterer, 2005, The Lancet.

Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubünden, Switzerland: two year follow-up.

P. Erne, P. Bonetti, W. Reinhart, 2011, Swiss medical weekly.

Enhanced external counterpulsation improves endothelial function in patients with coronary artery disease

S. Higano, D. Holmes, A. Lerman, 2003 .